Role of endothelium in pathogenesis of cerebral amyloid angiopathy
Role of endothelium in pathogenesis of cerebral amyloid angiopathy
批准号:
10624872
负责人:
Zvonimir S Katusic
金额:
$64.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-06-30
关键词:
Abeta clearanceAbeta synthesisAge-associated memory impairmentAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAmyloidosisArteriesBioinformaticsBlood VesselsBrainBrain InjuriesCell SeparationCerebral Amyloid AngiopathyCerebral hemisphere hemorrhageCerebrovascular PhysiologyCerebrovascular systemClinicalDementiaDepositionDevelopmentDiseaseDisease ProgressionElderlyEndothelial CellsEndotheliumEnzymesExperimental ModelsFluorescence-Activated Cell SortingGenesHomeostasisHomologous GeneHumanImpaired cognitionImpairmentIn VitroInjuryIntercellular FluidKnockout MiceLinkMicrovascular DysfunctionMolecularMusNerve DegenerationPathogenesisPathway interactionsPatientsPersonsPharmaceutical PreparationsPlayPreventionProductionProteinsRegulationReportingRiskRoleSignal TransductionSiteSporadic Cerebral Amyloid Angiopathyabeta accumulationabeta depositionaging brainalpha secretasebeta-site APP cleaving enzyme 1brain endothelial cellbrain parenchymacerebral microvasculaturecerebrovascularcerebrovascular pathologycognitive functiondesignexperimental studymolecular targeted therapiesmouse modelnext generationnext generation sequencingpreservationpreventtherapeutic developmenttherapeutic targettherapy designtranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Sporadic cerebral amyloid angiopathy (CAA) is a small vessel disease caused by cerebrovascular deposition
of amyloid-β (Aβ). CAA frequently overlaps with Alzheimer’s disease (AD), presumably because Aβ is
considered major culprit in development of AD pathology. Importantly, there is no disease-specific treatment
available to patients with CAA. Relevant to this project, molecular mechanisms underlying pathogenesis of
CAA are incompletely understood thereby limiting our ability to prevent initiation and progression of this
disease. Despite mechanistic differences between vascular-induced brain injury in CAA and
neurodegenerative injury in AD, clinically, CAA overlaps with AD and it is associated with more severe
cognitive impairment in AD patients. This application is designed to advance the concept that in early stages of
CAA, deposition of endothelium-derived Aβ in cerebral blood vessel wall is an important mechanism
contributing to pathogenesis of the disease. We performed extensive preliminary studies on cultured human
brain microvascular endothelial cells (BMECs), mouse microvessels, and brain endothelial cells isolated by
fluorescence activated cell sorting (FACS). Next generation sequencing (RNA-Seq) was used to determine
global gene expression profiles in human and murine cerebrovascular endothelium. Genetically modified mice
and a murine experimental model of CAA were used to validate and expand observations obtained in cultured
human endothelium. We identified previously unrecognized (Aβ-independent) endothelial functions of β-site
amyloid precursor protein (APP)-cleaving enzyme (BACE1) and its homologue (BACE2). Consistency between
findings in human and murine endothelium was in agreement with strong evolutionary conservation of BACE1
and BACE2. However, while endothelial BACE1 exerts detrimental vascular effects, endothelial BACE2
appears to be previously unrecognized and very important vascular protective molecule. Further preliminary
analyses of BACE1 and BACE2 function and signaling in endothelium of mice vulnerable to development of
CAA, suggested that dysfunctional BACE1 and BACE2 in endothelium promote elevated Aβ deposition in the
cerebral blood vessels. Based on these preliminary findings our working hypothesis is that endothelial BACE1
and BACE2 play distinct roles in cerebrovascular homeostasis and pathogenesis of CAA. We anticipate that
successful completion of this project will offer new opportunities to utilize endothelial BACE1 and BACE2 as
molecular targets for therapeutic interventions designed to prevent detrimental effects of CAA on
cerebrovascular and cognitive function.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/jnc.15929
发表时间:
2023-09
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[]
通讯作者:
Role of endothelium in pathogenesis of cerebral amyloid angiopathy
-
批准号:10311153
-
项目类别:
-
资助金额:$65.45万
-
财政年份:2021
-
负责人:Zvonimir S Katusic
-
依托单位:
Role of endothelium in pathogenesis of cerebral amyloid angiopathy
-
批准号:10478114
-
项目类别:
-
资助金额:$65.41万
-
财政年份:2021
-
负责人:Zvonimir S Katusic
-
依托单位:
Endothelial dysfunction in the cerebral circulation
-
批准号:8403744
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2012
-
负责人:Zvonimir S Katusic
-
依托单位:
Endothelial Dysfunction In The Cerebral Circulation
-
批准号:8596844
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2012
-
负责人:Zvonimir S Katusic
-
依托单位:
Endothelial dysfunction in the cerebral circulation
-
批准号:8216679
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2012
-
负责人:Zvonimir S Katusic
-
依托单位:
Endothelial Dysfunction In The Cerebral Circulation
-
批准号:8787484
-
项目类别:
-
资助金额:$45.09万
-
财政年份:2012
-
负责人:Zvonimir S Katusic
-
依托单位:
Mechanisms of endothelial repair after vascular injury
-
批准号:8061639
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Zvonimir S Katusic
-
依托单位:
Mechanisms of endothelial repair after vascular injury
-
批准号:7894630
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Zvonimir S Katusic
-
依托单位:
Mechanisms of endothelial repair after vascular injury
-
批准号:8312394
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2009
-
负责人:Zvonimir S Katusic
-
依托单位:
Tetrahydrobiopterin: regulator of endothelial function
-
批准号:7822183
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2009
-
负责人:Zvonimir S Katusic
-
依托单位:
Mechanisms of endothelial repair after vascular injury
-
批准号:7727733
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Zvonimir S Katusic
-
依托单位:
Heme oxygenase-1 VS eNOS gene transfer to cerebral arteries to prevent vasospasm
-
批准号:6661538
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2002
-
负责人:Zvonimir S Katusic
-
依托单位:
CEREBAL ARTERIAL ADVENTITIA AND VASOSPASM
-
批准号:2760454
-
项目类别:
-
资助金额:$25.98万
-
财政年份:1999
-
负责人:Zvonimir S Katusic
-
依托单位:
CEREBAL ARTERIAL ADVENTITIA AND VASOSPASM
-
批准号:6139563
-
项目类别:
-
资助金额:$26.76万
-
财政年份:1999
-
负责人:Zvonimir S Katusic
-
依托单位:
CEREBAL ARTERIAL ADVENTITIA AND VASOSPASM
-
批准号:6343890
-
项目类别:
-
资助金额:$27.5万
-
财政年份:1999
-
负责人:Zvonimir S Katusic
-
依托单位:
Nitric Oxide-Superoxide in Lipid Induced Vascular Diseas
-
批准号:6847866
-
项目类别:
-
资助金额:$34.21万
-
财政年份:1998
-
负责人:Zvonimir S Katusic
-
依托单位:
Nitric Oxide-Superoxide in Lipid Induced Vascular Diseas
-
批准号:6620201
-
项目类别:
-
资助金额:$34.3万
-
财政年份:1998
-
负责人:Zvonimir S Katusic
-
依托单位:
NITRIC OXIDE/SUPEROXIDE IN LIPID VASCULAR DISEASE
-
批准号:6351503
-
项目类别:
-
资助金额:$10.02万
-
财政年份:1998
-
负责人:Zvonimir S Katusic
-
依托单位:
Nitric Oxide-Superoxide in Lipid Induced Vascular Diseas
-
批准号:6400571
-
项目类别:
-
资助金额:$36.13万
-
财政年份:1998
-
负责人:Zvonimir S Katusic
-
依托单位:
Nitric Oxide-Superoxide in Lipid Induced Vascular Diseas
-
批准号:6702338
-
项目类别:
-
资助金额:$34.26万
-
财政年份:1998
-
负责人:Zvonimir S Katusic
-
依托单位: